We searched the literature through PubMed using the next keyphrases: (1) the GEMRITUX trial,38 RTX vs antiproteinuric treatment by itself groupings, reported no difference between both groupings in the principal end factors (CR or PR of proteinuria at six months)

We searched the literature through PubMed using the next keyphrases: (1) the GEMRITUX trial,38 RTX vs antiproteinuric treatment by itself groupings, reported no difference between both groupings in the principal end factors (CR or PR of proteinuria at six months). six months was 50% in the RPR-260243 RTX group vs…